Bollard Group LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 401 filers reported holding REPLIGEN CORP in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2023$6
-100.0%
42
-90.1%
0.00%
-100.0%
Q1 2022$80,000
-28.6%
4230.0%0.00%
-25.0%
Q4 2021$112,000
-8.2%
4230.0%0.00%0.0%
Q3 2021$122,000
+45.2%
4230.0%0.00%
+33.3%
Q2 2021$84,000
+2.4%
4230.0%0.00%0.0%
Q1 2021$82,000
-41.0%
423
-41.5%
0.00%
-40.0%
Q4 2020$139,000
+124.2%
723
+70.9%
0.01%
+150.0%
Q3 2020$62,000
+19.2%
4230.0%0.00%0.0%
Q2 2020$52,0004230.00%
Other shareholders
REPLIGEN CORP shareholders Q2 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders